Deconex Ir Tablet
Product Images NDC 50991-736

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Deconex Ir (NDC 50991-736). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Poly Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 50991-736-90deconex Ir Tablets90 Tablets (Deconex Ir Tablets 01)

Label of Deconex IR Tablets, an oral human OTC drug by Poly Pharmaceuticals, Inc. The label states it contains 90 tablets. Each tablet has 385 mg of Guaifenesin and 10 mg of Phenylephrine HCl. The product is identified as an expectorant and nasal decongestant. The label includes a barcode and tamper-evident foil seal warning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.